- Home
- MTCH vs CORT Comparison
MTCH vs CORT Comparison
Compare MTCH & CORT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MTCH
- CORT
- Stock Information
- Founded
- MTCH 1986
- CORT 1998
- Country
- MTCH United States
- CORT United States
- Employees
- MTCH N/A
- CORT N/A
- Industry
- MTCH Computer Software: Programming Data Processing
- CORT Biotechnology: Pharmaceutical Preparations
- Sector
- MTCH Technology
- CORT Health Care
- Exchange
- MTCH Nasdaq
- CORT Nasdaq
- Market Cap
- MTCH 7.6B
- CORT 7.5B
- IPO Year
- MTCH 2015
- CORT N/A
- Fundamental
- Price
- MTCH $32.73
- CORT $71.72
- Analyst Decision
- MTCH Buy
- CORT Strong Buy
- Analyst Count
- MTCH 19
- CORT 4
- Target Price
- MTCH $35.95
- CORT $142.00
- AVG Volume (30 Days)
- MTCH 4.1M
- CORT 1.6M
- Earning Date
- MTCH 07-29-2025
- CORT 07-28-2025
- Dividend Yield
- MTCH 2.34%
- CORT N/A
- EPS Growth
- MTCH N/A
- CORT 8.36
- EPS
- MTCH 2.03
- CORT 1.14
- Revenue
- MTCH $3,450,904,000.00
- CORT $685,446,000.00
- Revenue This Year
- MTCH $1.23
- CORT $35.83
- Revenue Next Year
- MTCH $4.17
- CORT $35.24
- P/E Ratio
- MTCH $16.03
- CORT $62.92
- Revenue Growth
- MTCH 0.40
- CORT 30.93
- 52 Week Low
- MTCH $26.39
- CORT $30.77
- 52 Week High
- MTCH $38.84
- CORT $117.33
- Technical
- Relative Strength Index (RSI)
- MTCH 59.37
- CORT 50.50
- Support Level
- MTCH $31.80
- CORT $66.49
- Resistance Level
- MTCH $34.07
- CORT $72.49
- Average True Range (ATR)
- MTCH 0.78
- CORT 2.85
- MACD
- MTCH 0.16
- CORT -0.09
- Stochastic Oscillator
- MTCH 66.58
- CORT 49.95
About MTCH Match Group Inc.
Match Group Inc is a provider of online dating products. The company's portfolio of brands includes Tinder, Hinge, Match, Meetic, OkCupid, Pairs, Plenty Of Fish, Azar, BLK, and more, each built to increase its user's likelihood of connecting with others. The company has four operating segments: Tinder, Hinge, Evergreen and Emerging, and Match Group Asia. The company generates the majority of its revenue from the Tinder segment.
About CORT Corcept Therapeutics Incorporated
Corcept Therapeutics Inc is a commercial-stage pharmaceutical company engaged in the discovery and development of medications that treat severe metabolic, oncologic and neuropsychiatric disorders by modulating the effect of the hormone cortisol. The company's compounds are being evaluated in clinical trials as potential treatments for a variety of serious disorders - hypercortisolism, advanced ovarian cancer, prostate cancer, ALS, and MASH.